Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

Test Name: AFB-MOTT Drug Sensitivity Test (Rapid Grower)

Maximum Days for Report: 21 days

The report for the AFB-MOTT Drug Sensitivity Test (Rapid Grower) can be obtained within a maximum of 21 days from the date of sample collection.

What are the prerequisites for the test AFB-MOTT Drug Sensitivity Test (Rapid Grower)

  • Specimen: Clinical isolate of Rapid Grower Mycobacteria
  • Media: Middlebrook 7H9 broth supplemented with oleic acid, albumin, dextrose, and catalase (OADC)
  • Incubation: 35-37°C for 14 days
  • Preparation of Inoculum: Suspension of the isolate in sterile saline adjusted to 0.5 McFarland turbidity standard
  • Antimicrobial agents: Linezolid, Amikacin, Moxifloxacin

What are the measure values for the test AFB-MOTT Drug Sensitivity Test (Rapid Grower)

  • Amikacin: Resistant if MIC ≥ 64 mcg/mL
  • Ciprofloxacin: Resistant if MIC ≥ 4 mcg/mL
  • Clarithromycin: Resistant if MIC ≥ 8 mcg/mL
  • Imipenem: Resistant if MIC ≥ 16 mcg/mL
  • Moxifloxacin: Resistant if MIC ≥ 4 mcg/mL

What does this test AFB-MOTT Drug Sensitivity Test (Rapid Grower) identify?

AFB-MOTT Drug Sensitivity Test (Rapid Grower)

  • Identifies drug sensitivity of Rapid Grower mycobacteria
  • This test is used to determine the most effective antibiotic treatment for infections caused by Rapid Grower mycobacteria
  • Rapid Grower mycobacteria include species like Mycobacterium fortuitum, Mycobacterium chelonae, and Mycobacterium abscessus

Why is this test AFB-MOTT Drug Sensitivity Test (Rapid Grower) taken?

AFB-MOTT Drug Sensitivity Test (Rapid Grower)

The AFB-MOTT Drug Sensitivity Test (Rapid Grower) is taken to determine the susceptibility of rapidly growing mycobacteria to various antibiotics. Rapidly growing mycobacteria, also known as non-tuberculous mycobacteria, are a group of bacteria that can cause infections in humans. These infections are often difficult to treat due to the resistance of the bacteria to many common antibiotics.

By performing this test, healthcare providers can identify which antibiotics are effective in treating infections caused by rapidly growing mycobacteria. This information is crucial for determining the most appropriate and effective treatment plan for patients with these types of infections.

No FAQs available.

Customer Google Rating